Oral Health Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Oral Health in Young Women Lacking

Women of childbearing age in the United States should be encouraged to maintain better oral care and visit the dentist routinely.

Fluoride in Primary Care for Children

The American Academy of Pediatrics (AAP) has issued a report regarding fluoride in the primary care setting.

FDA: Oral Viscous Lidocaine Warning

The FDA warns that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain.

MC3 for RA, Periodontitis

Melanocortin receptor type 3 (MC3) has protective properties for joint and periodontal tissues.

Rebuilding Teeth with Laser Therapy

Non-ionizing, low-power laser (LPL) treatment may be coming to a dentist office near you in the future.

Periodontitis Tied to RA

Periodontitis is independently associated with established seropositive rheumatoid arthritis (RA).

Methemoglobinemia, Benzocaine Warning

The FDA will allow manufacturers of OTC oral health care products containing benzocaine to include a product label warning on methemoglobinemia.

Coupons and Patient Assistance

Pass along free prescription and OTC drug coupons, vouchers, and rebates to help reduce your patients' healthcare costs.

News

Why Intense Exercise May Harm Your Teeth

Regular vigorous exercise is often associated with positive health outcomes such as weight loss, but it may actually increase the risk of dental caries and other oral health problems.

CDC: Oral Health in Young Women Needs Improvement

Women of childbearing age in the United States should be encouraged to maintain better oral care and visit the dentist routinely.

Fluoride in Primary Care for Children, Recommends AAP

The American Academy of Pediatrics (AAP) has issued a new clinical report with recommendations regarding fluoride for dental caries prevention in the primary care setting.

Melanocortin Receptor Agonist Can Treat RA, Periodontal Disease

Melanocortin receptor type 3 (MC3) has protective properties for joint and periodontal tissues, according to a new study.

Oral Viscous Lidocaine Not For Teething Pain, Warns FDA

The FDA has issued a warning that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain, and that OTC topical medications may also be harmful and should not be used.

Featured courses from mycme

SCOPE of Pain: Safe and Competent Opioid Prescribing EducationExternal web site

SCOPE of Pain is an educational program that helps you safely and competently manage your ...

CME|CE 3.00 Credits

Accelerated cardiovascular disease; Oral health during pregnancyExternal web site

This activity is taken from the December 2012 issue of JAAPA. It includes the CME ...

CME 1.00 Credits

Maximizing oral health in children; Vasculitis: Diagnosis and treatmentExternal web site

This activity is taken from the July 2012 issue of JAAPA. It includes the CME ...

1.00 Credits

Sign Up for Free e-newsletters